News &

Media Contact

Amy Merves
Manager of
Media Relations



Fox Chase Cancer Center President Robert C. Young Elected First Vice President of the American Cancer Society

PHILADELPHIA (December 14, 1999) -- Robert C. Young, M.D., of Philadelphia's Chestnut Hill section, president of Fox Chase Cancer Center, has been elected first vice president of the national American Cancer Society (ACS) for 2000-2001. Young is a director-at-large of the American Cancer Society's national board of directors and at the end of 1999 completes his term as chairman of the medical affairs committee.

Internationally known for his work in the treatment of lymphoma and ovarian cancer, Dr. Young is a past president of the American Society of Clinical Oncology, one of the world's largest oncology societies, and president of the International Gynecologic Cancer Society.

A medical oncologist, Young is the author of more than 350 peer-reviewed publications, primarily concerning new treatments for lymphoma and ovarian cancer. Based on the number of medical literature citations, he was one of the top 400 scientist authors in the U.S. for 1980-1990, according to the Institute for Scientific Information.

Recently, Young instituted the world's first comprehensive research initiative to prevent cancer, to be housed in a dedicated Cancer Prevention Pavilion at Fox Chase. The facility will contain research programs ranging from basic laboratory studies to clinical services, including clinical trials of medications to prevent cancer.

Young serves on the Board of Scientific Advisors of the National Cancer Institute. He is also chairman of the board of the National Comprehensive Cancer Network, a nationwide alliance of leading academic cancer centers dedicated to insuring the highest quality, cost-effective cancer care.

A fellow of the American College of Physicians, Young is also a member of the prestigious American Society of Clinical Investigation. He has served as a member of the subspecialty board on medical oncology for the American Board of Internal Medicine and on the experimental therapeutics study section of the National Cancer Institute.

He is associate editor of the Journal of Clinical Oncology and chairman of the editorial board of Oncology Times. In 1995, he served as chairman of the General Motors Cancer Research Foundation's Charles F. Kettering Selections Committee.

Born in Columbus, Ohio, Young received his B.Sc. degree in zoology in 1960 from Ohio State University and his M.D. in 1965 from Cornell University Medical College. Following his internship at New York Hospital, he completed his residency at NCI and Yale-New Haven Medical Center. He is board-certified in internal medicine, hematology and oncology by the American Board of Internal Medicine.

Young came to Fox Chase in 1988 from the National Cancer Institute, where he was associate director of the centers and community oncology program. Previously he served as chief of NCI's medicine branch for 14 years.

Gerald L. Woolam, M.D., of Lubbock, Texas, was elected ACS president and John R. Kelly, Ph.D., of Gulfport, Miss., was elected chairman of the board. President-elect is Dileep G. Bal, M.D., M.S., M.P.H., of Fair Oaks, Calif., and John C. Baity, Esq., of New York is chairman-elect. H. Fred Mickelson of Newberg, Ore., was elected vice chairman.

The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy and service.

Fox Chase Cancer Center is one of 37 National Cancer Institute-designated comprehensive cancer centers in the nation. Fox Chase activities include basic and clinical research; prevention, detection and treatment of cancer; and community outreach programs.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 1999 News Releases »